当前位置:主页 > 医学论文 > 妇产科论文 >

术后化疗在IA2-IB1期单纯低分化宫颈鳞癌患者预后研究

发布时间:2018-01-28 04:37

  本文关键词: 低分化 宫颈鳞癌 化疗 出处:《广西医科大学》2017年硕士论文 论文类型:学位论文


【摘要】:目的:探讨术后辅助化疗对IA2-IB1期单纯低分化宫颈鳞癌患者预后的影响。方法:采用回顾性分析方法,收集2003年2月~2014年2月就诊于广西医科大学第一附属医院妇科的76例IA2-IB1期单纯低分化高危因素宫颈鳞癌手术患者的病例资料,根据术后辅助化疗情况,分为观察组(手术+术后化疗组42例)和对照组(单纯手术组34例),对比两组患者预后生存指标,并总结观察组患者的化疗毒副反应。结果:所有患者累计总生存率、无复发生存率、无远处转移生存率及无局部复发生存率分别为93.9%、94.7%、96.1%、98.7%,其中观察组患者总生存率、无复发生存率均优于对照组(P0.05),且远处转移率(0%)低于对照组(8.8%),而无局部复发生存率两组患者比较差异无显著性(P0.05)。观察组所有患者均完成了所有疗程化疗,化疗毒副反应主要为胃肠道反应23.81%(10/42),骨髓抑制19.04%(8/42),周围神经障碍14.29%(6/42),肝肾功能损害4.76%(2/42),均为可逆性。结论:针对单纯低分化高危因素的IA2-IB1期宫颈鳞癌患者,术后辅助化疗不仅提高患者总生存率,还降低复发率,且化疗不良反应的可逆性在提高患者的生活质量中具有一定优势,是一种可行的治疗选择。
[Abstract]:Objective: to investigate the effect of postoperative adjuvant chemotherapy on prognosis of patients with simple poorly differentiated squamous cell carcinoma of the cervix (IA2-IB1). From February 2003 to February 2014, 76 cases of cervical squamous cell carcinoma (SCC) with low differentiation and high risk factors were collected from gynecological department of the first affiliated Hospital of Guangxi Medical University. According to the postoperative adjuvant chemotherapy, the patients were divided into observation group (42 cases of postoperative chemotherapy group) and control group (34 cases of simple operation group). Results: the cumulative overall survival rate, recurrence free survival rate, distant metastasis free survival rate and local recurrence free survival rate of all patients were 93.9% or 94.7% respectively. The overall survival rate and recurrence free survival rate of the patients in the observation group were better than those in the control group (P 0.05), and the distant metastasis rate was lower than that in the control group (P < 0.01). However, there was no significant difference between the two groups in the survival rate of no local recurrence (P 0.05). All the patients in the observation group completed all the courses of chemotherapy. The side effects of chemotherapy were mainly gastrointestinal reaction 23.81% 10 / 42, bone marrow suppression 19.0410 / 42, peripheral nerve disturbance 14.29 / 42). Liver and kidney function damage 4.76 / 42%, are reversible. Conclusion: simple low differentiation risk factors for IA2-IB1 patients with cervical squamous cell carcinoma. Postoperative adjuvant chemotherapy not only improves the overall survival rate, but also reduces the recurrence rate. The reversibility of adverse reactions of chemotherapy has some advantages in improving the quality of life of patients, and it is a feasible treatment choice.
【学位授予单位】:广西医科大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R737.33

【参考文献】

相关期刊论文 前10条

1 李双;李雄;张媛;周航;唐方徐;贾瑶;胡婷;孙海英;杨茹;陈亦乐;程晓东;吕卫国;吴丽;周金;王少帅;黄科程;王琳;姚远;杨其峰;杨兴升;张庆华;韩晓兵;林仲秋;邢辉;曲們們;蔡红兵;宋晓婕;田晓予;沈健;奚玲;李科珍;邓东锐;汪辉;王常玉;吴明富;朱涛;陈刚;高庆蕾;王世宣;胡俊波;孔北华;谢幸;马丁;;宫颈癌的手术-病理分期和评分系统的建立和验证[J];现代妇产科进展;2016年11期

2 李昭昭;张春瑜;王新玲;夏鸣;;术后辅助治疗对早期单纯低分化宫颈鳞癌患者预后的影响[J];中国全科医学;2016年30期

3 吴乾凤;高国兰;孔为民;;Ⅰ~ⅡA2期宫颈癌淋巴结转移高危因素及对预后的影响[J];中国妇产科临床杂志;2016年05期

4 彭俊;黄勇;;90例年轻宫颈癌患者临床特征及术后复发和预后相关因素分析[J];实用妇产科杂志;2016年01期

5 熊万春;;影响低危型宫颈癌患者辅助化疗预后的相关因素[J];实用癌症杂志;2015年05期

6 杜俊瑶;张新;李联];王纯雁;王晓彬;于明新;;同步放化疗与单纯放疗治疗中晚期宫颈癌疗效及毒性反应比较研究[J];中国实用妇科与产科杂志;2015年03期

7 高琴;张丹丹;白帆;罗芳;李芳兵;;紫杉醇联合铂类方案治疗中晚期宫颈癌患者的临床疗效及对血清CYFRA21-1、SCC-Ag的影响[J];疑难病杂志;2015年01期

8 胡尚英;郑荣寿;赵方辉;张思维;陈万青;乔友林;;1989至2008年中国女性子宫颈癌发病和死亡趋势分析[J];中国医学科学院学报;2014年02期

9 孙菲;李艳芳;刘继红;熊樱;;208例低危型宫颈癌患者的辅助治疗及预后相关因素分析[J];南方医科大学学报;2014年03期

10 贺红英;曾定元;谭广萍;曲晓力;韦露薇;;Ⅰa2-Ⅰb1期仅有低分化高危因素宫颈鳞癌患者术后治疗模式的探讨[J];中国妇幼保健;2014年07期



本文编号:1469787

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/1469787.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户320b3***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com